Jin Medical International Ltd.
For the period ended Jun 29, 2026. Filed Jun 29, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jun 29, 2026 · Filed Jun 29, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · 6.2 Authority; Binding Effect
6.2 Authority; Binding Effect
Each of the Company and WFOE has full corporate power and authority to execute and deliver each Transaction Document to which it is a party and to perform its obligations thereunder, subject to receipt of the Company shareholder approvals and Nasdaq-related requirements contemplated hereby. Upon execution, each such Transaction Document will constitute a legal, valid and binding obligation of the Company or WFOE, enforceable in accordance with its terms.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.